Selection bias in the assessment of gene-environment interaction in case-control studies.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 12882948)

Published in Am J Epidemiol on August 01, 2003

Authors

Libby M Morimoto1, Emily White, Polly A Newcomb

Author Affiliations

1: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Articles citing this

Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet (2007) 3.92

Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health (2008) 2.02

Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes. Environ Health Perspect (2010) 1.62

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res (2010) 1.51

Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology (2010) 1.30

Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. Am J Epidemiol (2009) 1.27

A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res (2005) 1.05

Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol (2012) 0.99

Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. Cancer Epidemiol Biomarkers Prev (2014) 0.98

Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients. BMC Pregnancy Childbirth (2012) 0.91

Childhood brain tumors and maternal cured meat consumption in pregnancy: differential effect by glutathione S-transferases. Cancer Epidemiol Biomarkers Prev (2011) 0.90

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. Int J Cancer (2014) 0.90

Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease. PLoS Genet (2014) 0.86

Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol (2013) 0.86

Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett (2006) 0.86

Design and analysis issues in gene and environment studies. Environ Health (2012) 0.86

Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. Cancer Epidemiol (2010) 0.86

Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat (2010) 0.85

Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev (2014) 0.83

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer (2013) 0.83

Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.81

A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication. Breast Cancer Res Treat (2013) 0.81

Parental smoking and risk of childhood brain tumors by functional polymorphisms in polycyclic aromatic hydrocarbon metabolism genes. PLoS One (2013) 0.77

Articles by these authors

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol (2013) 7.97

The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77

Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65

Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17

Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA (2003) 4.72

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27

Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14

Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11

Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst (2013) 3.06

Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst (2013) 2.99

Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst (2004) 2.84

Identification of Lynch syndrome among patients with colorectal cancer. JAMA (2012) 2.77

Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73

From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol (2006) 2.67

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. J Natl Cancer Inst (2013) 2.45

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44

Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol (2003) 2.38

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30

Geocoding addresses from a large population-based study: lessons learned. Epidemiology (2003) 2.27

Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology (2004) 2.22

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22

Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev (2008) 2.12

Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev (2002) 2.08

Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet (2006) 2.02

Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00

Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst (2010) 1.99

Screening mammography: clinical image quality and the risk of interval breast cancer. AJR Am J Roentgenol (2002) 1.97

Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96

Buccal cell DNA yield, quality, and collection costs: comparison of methods for large-scale studies. Cancer Epidemiol Biomarkers Prev (2002) 1.92

A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med (2004) 1.89

Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev (2004) 1.82

Yoga practice is associated with attenuated weight gain in healthy, middle-aged men and women. Altern Ther Health Med (2005) 1.79

Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev (2009) 1.75

The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74

Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev (2009) 1.72

Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.71

Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69

Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Dis Colon Rectum (2013) 1.65

Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol (2009) 1.63

A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol (2009) 1.63

Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer (2010) 1.62

Risk factors for renal cell carcinoma in the VITAL study. J Urol (2013) 1.62

Cadmium exposure and breast cancer risk. J Natl Cancer Inst (2006) 1.61

Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59

Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58

Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology (2008) 1.56

Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.56

Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat (2013) 1.55

Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol (2011) 1.52

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52

Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer (2006) 1.48

Test-retest reliability of the Women's Health Initiative physical activity questionnaire. Med Sci Sports Exerc (2009) 1.48

BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev (2012) 1.48

Potential exposure to PCBs, DDT, and PBDEs from sport-caught fish consumption in relation to breast cancer risk in Wisconsin. Environ Health Perspect (2004) 1.47

Postoophorectomy estrogen use and breast cancer risk. Obstet Gynecol (2012) 1.46

Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev (2005) 1.45

Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol (2009) 1.44

Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res (2013) 1.42

Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol (2009) 1.42

Correlates of age at menarche among sixth grade students in Wisconsin. WMJ (2005) 1.42

Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.42

Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage (2002) 1.40

Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res (2006) 1.37

Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.34

Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control (2003) 1.32

Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms. AJR Am J Roentgenol (2002) 1.32

Assessment of a one-page questionnaire on long-term recreational physical activity. Epidemiology (2004) 1.32

Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use. Cancer Res (2006) 1.31

Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control (2004) 1.30

Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol (2010) 1.30

Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology (2006) 1.30

Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat (2006) 1.29

Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn (2011) 1.27

Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr (2008) 1.26

Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control (2012) 1.26

Anthropometrics and prostate cancer risk. Am J Epidemiol (2007) 1.25

Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.25

Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer (2011) 1.23

Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control (2007) 1.22

Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol (2012) 1.21

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut (2010) 1.20

Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2002) 1.20

Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS (2013) 1.19

Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med (2004) 1.18

Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.18

A novel custom resequencing array for dilated cardiomyopathy. Genet Med (2010) 1.18

Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev (2008) 1.18

Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control (2006) 1.17

Cadmium exposure and cancer mortality in the Third National Health and Nutrition Examination Survey cohort. Occup Environ Med (2011) 1.17

Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev (2010) 1.15